ArticleThe Journal of infection2021
Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed.
- Clinical characteristics of pyogenic liver abscess patients with multiple organ dysfunction syndrome and development and validation of a predictive model.Frontiers in cellular and infection microbiology · 2026Article
- Development and validation of a predictive model for invasive syndrome in patients withFrontiers in medicine · 2025Article
- Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021.BMC public health · 2024Article
- Epidemiology, clinical features and outcomes of hospitalized patients with COVID-19 by vaccination status: a multicenter historical cohort study.Virology journal · 2024Article
- COVID-19 breakthrough infections among people living with and without HIV: A statewide cohort analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024Article
- Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort Study.The Journal of infectious diseases · 2024Article
- COVID-19 Breakthrough Infections among Medical Students under the SLICE and CLARO Programs: Ateneo School of Medicine and Public Health Experience.Acta medica Philippina · 2024Article
- Article
- SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022.Emerging infectious diseases · 2023Article
- Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19.The Journal of infectious diseases · 2023Article
- Comparison of self-reported symptoms in COVID-19 patients who had or had not previously received COVID-19 mRNA vaccination.Human vaccines & immunotherapeutics · 2023Article
- Transmission and Risk Factors of COVID-19 among Health Care Workers.Seminars in respiratory and critical care medicine · 2023Review
- Are the thorax Computed Tomography findings of ICU patients diagnosed with COVID-19 pneumonia related to the duration of hospital stay and mortality?Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2023Article
- Article
- Current and Emerging Knowledge in COVID-19.Radiology · 2023Review
- Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants.iScience · 2022Article
- Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK).The Lancet regional health. Europe · 2022Article
- Imaging and Clinical Features of COVID-19 Breakthrough Infections: A Multicenter Study.Radiology · 2022Article
- Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.JAMA network open · 2022Article
- Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi Arabia.Journal of infection and public health · 2022Article
Corrections and comments
- Comment on
Authors and funding
6 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.